Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ibα fragment

Mitsuru Murata, Susan R. Russell, Zaverio M. Ruggeri, Jerry Ware

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The platelet GP Ib-IX receptor supports platelet adhesion and activation by binding to vWf in the exposed subendothelial matrix. An abnormal GP Ib-IX complex exists in platelet-type or pseudo-von Willebrand disease and has a characteristic increased affinity for soluble vWf resulting in impaired hemostatic function due to the removal of larger vWf multimers from the circulation. Genetic studies within an afflicted family have demonstrated that the disease is linked to a Gly233 → Val amino acid substitution within the α-subunit of the oligomeric GP Ib-IX complex (Miller, J. L., D. Cunningham, V. A. Lyle, and C. L. Finch. 1991. Proc. Natl. Acad. Sci. USA. 88:4761-4765). To evaluate the functional consequences of this mutation, we constructed a recombinant analogue of the α-subunit of GP Ib containing Val233. Experiments comparing molecules with either Gly233 or Val233 revealed that the Val substitution generates a molecule with increased affinity for vWf. The recombinant fragment reproduces the functional abnormality of the GP Ib-IX complex in platelet-type von Willebrand disease, thus establishing the molecular basis of the bleeding disorder within this family. Moreover, it becomes apparent that structural elements responsible for the regulation of hemostasis through modulation of vWf affinity for platelets reside within the α-subunit of the GP Ib-IX complex.

Original languageEnglish
Pages (from-to)2133-2137
Number of pages5
JournalJournal of Clinical Investigation
Volume91
Issue number5
DOIs
Publication statusPublished - 1993 May
Externally publishedYes

    Fingerprint

Keywords

  • Genetic disease
  • Hemostasis
  • Platelet adhesion
  • Thrombosis
  • Von Willebrand factor

ASJC Scopus subject areas

  • Medicine(all)

Cite this